NCT03734861View on ClinicalTrials.gov

The Study is Enrolling Kids From 8 to 17 Years Old. The BreathSmart Device Attaches to the Inhaler to Measure Adherence.

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Asthma
Interventions
DEVICE

BreatheSmart System

"* BreatheSmart System: a mobile application that tracks medication usage and sends real time reminders~* HeroTracker sensor that counts dosage and monitors real-time medication adherence~* CoheroConnect provider portal that allows the Investigator to monitor adherence"

OTHER

Standard of Care

These patients are reminded to adhere to the prescribed standard of care therapy provided by their clinician during their clinical encounters and when the family calls to report an illness.

Trial Locations (1)

06106

Connecticut Children's Medical Center, Hartford

All Listed Sponsors
lead

Connecticut Children's Medical Center

OTHER

NCT03734861 - The Study is Enrolling Kids From 8 to 17 Years Old. The BreathSmart Device Attaches to the Inhaler to Measure Adherence. | Biotech Hunter | Biotech Hunter